New antibiotic approved for community-acquired infections.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology*; D000075202:Contraindications; D024841:Fluoroquinolones; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D011014:Pneumonia / Q000188:drug therapy; D015363:Quinolones / Q000627:therapeutic use*; D012749:Sexually Transmitted Diseases / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D010879:Piperazines; D015363:Quinolones; C075375:grepafloxacin